Thymosin Alpha-1 (TA1) 10mg (HPLC-Verified / Batch COA)⁠

Thymosin Alpha-1 (TA1) 10mg Reagent | High-Capacity Synthetic Thymic Peptide

Thymosin Alpha-1 (TA1) is an N-terminally acylated synthetic peptide comprised of 28 amino acids. It structurally corresponds to the naturally occurring peptide isolated from thymic tissue fractions. In physiological systems, endogenous TA1 is a primary driver of cell-mediated immunity, acting directly on immature lymphoid progenitor cells to dictate specific lineage maturation and functional adaptation profiles.

Within cellular immunology and advanced immune modulation research, this expanded 10mg Thymosin Alpha-1 configuration serves as a vital reference compound for high-throughput or long-duration testing matrices. It allows investigators to consistently map out the exact molecular signaling events required to promote T-helper ($T_H1$) and cytotoxic T-cell development, while offering an interactive model for observing cellular resistance markers and immune balance behaviors in vitro without intermediate batch changes.

Batch-Specific HPLC Analysis & Validation

To ensure the strict reproducibility demands required for continuous cellular screening, this immune modulation asset undergoes rigorous quality validation:

• HPLC Purity Certification: High-Performance Liquid Chromatography validation ensures a certified chemical purity of ≥99.0%, completely mitigating the threat of structural anomalies or sequence truncation.
• Mass Spectrometry Conformance: Confirms the absolute molecular mass profile matches the exact 28-amino acid sequence mapping perfectly.
• Analytical COA Security: Lot-specific Certificates of Analysis accompany every manufacturing batch to guarantee baseline consistency across sequential experiments.

Experimental Research Context & Mechanisms

Preclinical assay profiles implementing Thymosin Alpha-1 10mg target several key immune and cellular response vectors:

• T-Cell Maturation Mechanics: Tracking the specific phenotypic markers expressed during the differentiation of primitive CD4-/CD8- lymphocytes into mature immunocompetent lineages.
• Toll-Like Receptor (TLR) Signaling: Evaluating downstream MyD88-dependent pathways following targeted interaction with Toll-Like Receptors 3 and 9 within isolated cell cultures.
• Cytokine Transcription Modulation: Measuring the up-regulation vectors of Interferon-gamma (IFN-γ), Interleukin-2 (IL-2), and Tumor Necrosis Factor-alpha (TNF-α) in stimulated macrophage models.

Laboratory Storage & Handling Protocols

To prevent structural peptide degradation, primary sequence cleavage, or loss of biological activity:

• Lyophilized Protection: Keep unopened, vacuum-sealed glass vials stored long-term within a laboratory freezer maintained strictly at -20°C. Shield the compound assembly from persistent light exposure.
• Reconstitution Calibration: Ensure the glass vial equalizes with room temperature markers completely before removing the vacuum seal or introducing solvent. Reconstitute using Sterile Bacteriostatic Water or normal saline solution.
• Liquid Phase Management: Post-dissolution, maintain the resulting compound mixture inside a dark refrigeration unit between 2°C and 6°C. Avoid mechanical vortexing or intense physical agitation. Complete all experimental sampling sequences within 10 to 14 days of mixing.